title: Antiplatelet therapy plus moderate intensity anticoagulation is safe and effective in people with atrial fibrillation. Commentary.
authors.affiliation: Division of Cardiology, Department of Medicine, University of British Columbia, Canada.
authors.forename: Karin H
authors.initials: KH
authors.lastname: Humphries
authors.forename: Charles R
authors.initials: CR
authors.lastname: Kerr